$17.8 Billion is the total value of Point72 Asset Management, L.P.'s 809 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GDX | VANECK VECTORS ETF TRcall | $23,184,000 | -3.2% | 1,050,000 | 0.0% | 0.13% | -2.3% | |
| SMMT | SUMMIT THERAPEUTICS PLCspons ads | $9,126,000 | -14.2% | 801,231 | 0.0% | 0.05% | -13.6% | |
| ALK | ALASKA AIR GROUP INCcall | $8,976,000 | -2.7% | 100,000 | 0.0% | 0.05% | -2.0% | |
| CME | CME GROUP INC | $7,518,000 | +5.4% | 60,032 | 0.0% | 0.04% | +5.0% | |
| SLCA | U S SILICA HLDGS INCcall | $3,549,000 | -26.0% | 100,000 | 0.0% | 0.02% | -25.9% | |
| GILD | GILEAD SCIENCES INCcall | $2,031,000 | +4.2% | 28,700 | 0.0% | 0.01% | 0.0% | |
| XENE | XENON PHARMACEUTICALS INC | $977,000 | -21.3% | 310,179 | 0.0% | 0.01% | -28.6% | |
| ACOR | ACORDA THERAPEUTICS INCput | $788,000 | -6.2% | 40,000 | 0.0% | 0.00% | -20.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 41 | Q2 2024 | 8.3% |
| CME GROUP INC | 41 | Q2 2024 | 0.3% |
| AMAZON COM INC | 39 | Q2 2024 | 3.2% |
| META PLATFORMS INC | 38 | Q1 2024 | 2.2% |
| XENON PHARMACEUTICALS INC | 38 | Q2 2024 | 0.4% |
| CSX CORP | 37 | Q2 2024 | 1.3% |
| BUNGE LIMITED | 37 | Q2 2023 | 1.5% |
| VULCAN MATLS CO | 37 | Q2 2024 | 0.9% |
| BERRY PLASTICS GROUP INC | 37 | Q1 2024 | 0.8% |
| GENERAL MTRS CO | 36 | Q2 2024 | 1.1% |
View Point72 Asset Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Sphere Entertainment Co. | June 24, 2024 | 1,560,170 | 5.5% |
| UroGen Pharma Ltd. | June 24, 2024 | 2,569,826 | 6.2% |
| Olema Pharmaceuticals, Inc. | June 14, 2024 | 3,225,250 | 5.7% |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | June 10, 2024 | 4,481,050 | 3.4% |
| Rapid7, Inc. | May 21, 2024 | 3,121,415 | 5.0% |
| Corvus Pharmaceuticals, Inc. | May 09, 2024 | 17,050,384 | 9.9% |
| Avid Bioservices, Inc. | April 26, 2024 | 3,226,006 | 5.1% |
| SUTRO BIOPHARMA, INC. | April 05, 2024 | 5,791,505 | 7.7% |
| Fox Corp | March 26, 2024 | 12,046,118 | 5.0% |
| LENZ Therapeutics, Inc. | March 25, 2024 | 864,942 | 3.4% |
View Point72 Asset Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-09-16 |
| SC 13G | 2024-09-05 |
| N-PX | 2024-09-03 |
| 13F-HR/A | 2024-08-19 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-07-02 |
| SC 13G | 2024-06-24 |
| SC 13G | 2024-06-24 |
| SC 13G | 2024-06-14 |
| SC 13G | 2024-06-10 |
View Point72 Asset Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.